Position in SRPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,083,234
+$5,035,401 QoQ
Shares Held
394,170
+318.8% QoQ
Ownership
0.373%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#46
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. SRPT ranks #23 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,083,234 | 394,170 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,047,833 | 94,110 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,032,564 | 94,450 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,770,913 | 91,900 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $549,337 | 32,125 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,214,932 | 50,375 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,400,263 | 27,965 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,046,191 | 24,391 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,349,952 | 8,544 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $279,244 | 2,157 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $226,898 | 2,353 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $286,442 | 2,363 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $282,062 | 2,463 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,544,754 | 18,463 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $422,819 | 3,263 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,528,490 | 22,874 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $6,144,769 | 81,974 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $30,941,299 | 396,074 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,266,738 | 25,172 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $228,610 | 2,472 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $207,721 | 2,672 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $202,423 | 2,716 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $8,165,958 | 47,897 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $14,464 | 103 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $8,658 | 54 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $6,358 | 65 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||